Venture Life (VLG) AI Stock Analysis

Venture Life Group PLC has posted its Annual Report and Accounts for the period ended 31 May 2026, together with the notice of its Annual General Meeting, to shareholders, with the documents also available on the company’s website. The AGM is schedul...

Venture Life Group has transferred 110,000 ordinary shares out of treasury to satisfy an employee’s exercised options under its share option scheme, a routine move that slightly reduces its treasury stock while leaving overall issued share capital at...

Venture Life Group PLC has reported its current issued share capital and voting rights structure as of 30 September 2026, in line with UK financial conduct disclosure requirements. The company has 128,860,145 ordinary shares of 0.3 pence each in issu...

Venture Life Group’s chief financial officer Daniel Wells has increased his personal stake in the consumer healthcare company, purchasing 14,760 ordinary shares at 67.7 pence each on the London Stock Exchange. Following the transaction, Wells now ben...

Venture Life Group, a specialist in consumer self-care healthcare products ranging from women’s intimate health to ENT care and infection prevention, sells its brands through pharmacies, health and beauty outlets, grocery multiples and online channel...

Venture Life Group PLC, a U.K.-based international consumer self-care company, develops and commercialises healthcare products such as Balance Activ, Earol, Lift, Glucogel and Health & Her, targeting areas from women’s intimate health to ENT care, en...

Venture Life Group PLC, a UK-headquartered international consumer self-care company, develops and commercialises over-the-counter healthcare products spanning women’s intimate care, ENT support, energy and glucose management and hormonal health. Its...

Venture Life has completed a major strategic transformation during the seventeen-month period to 31 May 2026, divesting its contract development and manufacturing arm and oral care brands to focus on its core consumer healthcare portfolio. Continuing...

Venture Life Group plc, a UK-based international consumer self-care specialist, develops and commercialises over-the-counter products such as Balance Activ, Earol, Lift, Glucogel and Health & Her, which are distributed worldwide through retail and on...

Venture Life Group PLC has continued executing its previously announced share buyback programme, purchasing 192,641 ordinary shares at a volume-weighted average price of 67.80 pence per share through its broker Cavendish Capital Markets. The acquired...

Venture Life Group PLC will host a live investor presentation on 1 October 2026 via the Investor Meet Company platform to discuss its final results for the 17-month period ended 31 May 2026. The session will be led by chief executive Jerry Randall, c...

Venture Life Group has executed a further tranche of its share buyback programme, repurchasing 146,788 ordinary shares at a volume-weighted average price of 67.80 pence per share through Cavendish Capital Markets. The repurchased shares will be held...

Venture Life Group has continued its share buyback programme by purchasing 105,054 ordinary shares at a volume weighted average price of 67.80 pence, with the shares to be held in treasury rather than cancelled. Following this transaction, the compan...

Venture Life Group PLC, a UK-based consumer healthcare specialist, develops and commercialises self-care products ranging from women’s intimate health and ENT care to glucose management and hormonal lifecycle support. Its brands are sold globally via...

Venture Life Group PLC, a UK-headquartered consumer self-care specialist, develops and commercialises a diverse portfolio of healthcare products across women’s intimate health, ENT care, energy and glucose management and hormonal support. These produ...

Venture Life Group plc has executed a further tranche of its share buyback programme, repurchasing 102,666 ordinary shares at a volume-weighted average price of 68.10 pence through Cavendish Capital Markets. The shares will be held in treasury, refle...

Venture Life Group has repurchased 35,000 ordinary shares at a volume-weighted average price of 67.90 pence under its ongoing share buyback programme, and will hold these shares in treasury. Following this transaction, the company has 128,860,145 sha...

Venture Life Group PLC has continued to execute its share buyback programme, repurchasing 24,302 ordinary shares on 9 September 2026 at a volume-weighted average price of 66.32 pence per share through Cavendish Capital Markets. The repurchased shares...

Venture Life Group has continued to execute its previously announced share buyback programme, acquiring 45,459 ordinary shares at a volume-weighted average price of 66 pence per share through Cavendish Capital Markets. The repurchased shares will be...

Venture Life Group PLC, an AIM-listed leader in global consumer healthcare product innovation and commercialisation, has strengthened its capital management strategy with a share buyback transaction executed under its previously announced programme....

Venture Life Group has continued its share buyback programme, repurchasing 85,319 ordinary shares at a volume-weighted average price of 65.70 pence per share, with the shares to be held in treasury. Following this latest transaction, the company now...

Venture Life Group has disclosed its latest capital structure, confirming total issued share capital of 128,860,145 ordinary shares of 0.3 pence each, with 8,726,795 shares held in treasury, resulting in 120,133,350 voting rights. Each ordinary share...

Venture Life Group, an international consumer healthcare company specialising in self-care products such as Balance Activ, Earol, Lift, Glucogel and Health & Her, distributes its brands globally through pharmacies, retail chains and online channels,...

Venture Life Group has executed a further tranche of its recently announced share buyback programme, repurchasing 135,700 ordinary shares at a volume‑weighted average price of 66.12 pence, with the shares to be held in treasury. Following this transa...

Venture Life Group PLC has executed a further purchase of its own shares under the share buyback programme announced on 20 August 2026. The company acquired 77,902 ordinary shares at a volume‑weighted average price of 65.65 pence per share through Ca...